Taste Masking용 의약품 부형제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide Pharmaceutical Excipients for Taste Masking Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Pharmaceutical Excipients for Taste Masking Market Size (2024E): USD 985.6 million
• Projected Market Value (2033F): USD 1,539.2 million
• Global Market Growth Rate (CAGR 2024 to 2033): 5.1%

Pharmaceutical Excipients for Taste Masking Market - Report Scope:

Pharmaceutical excipients for taste masking play a crucial role in the formulation of medications, improving patient compliance by masking unpleasant tastes and odors. These excipients are used across various dosage forms, including tablets, syrups, and powders, to enhance the palatability of pharmaceutical products. The market caters to pharmaceutical manufacturers, contract research organizations (CROs), and contract manufacturing organizations (CMOs), offering a range of excipients including flavoring agents, sweeteners, and coating materials.

Market Growth Drivers:

The global pharmaceutical excipients for taste masking market is propelled by several key factors, including the rising demand for pediatric and geriatric medicines, which require effective taste masking solutions to improve patient adherence. Increased consumer preference for orally administered medications and advancements in excipient technologies, such as the development of new flavor-masking agents and advanced coating materials, further drive market expansion. The growth of the over-the-counter (OTC) pharmaceutical sector and the increasing focus on personalized medicine also contribute to the demand for innovative taste masking solutions.

Market Restraints:

Despite promising growth prospects, the pharmaceutical excipients for taste masking market faces challenges related to the high cost of advanced excipient technologies and regulatory hurdles. Stringent regulations governing the safety and efficacy of excipients impose compliance burdens on manufacturers and increase operational costs. Additionally, the limited availability of taste masking solutions for certain drug formulations and the need for continuous R&D investments to develop novel excipients pose challenges for market penetration.

Market Opportunities:

The pharmaceutical excipients for taste masking market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving pharmaceutical formulations. The integration of advanced technologies, such as nanotechnology and polymer-based excipients, enhances taste masking effectiveness and opens new avenues for market growth. Furthermore, the expanding pharmaceutical industry in emerging markets and the increasing emphasis on patient-centric drug development offer opportunities for market players to introduce cost-effective and efficient taste masking solutions. Strategic partnerships, investments in R&D, and the introduction of user-friendly excipients are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic taste masking landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the pharmaceutical excipients for taste masking market globally?
• Which excipient types and applications are driving taste masking adoption across different pharmaceutical formulations?
• How are technological advancements reshaping the competitive landscape of the pharmaceutical excipients for taste masking market?
• Who are the key players contributing to the pharmaceutical excipients for taste masking market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global pharmaceutical excipients for taste masking market?

Competitive Intelligence and Business Strategy:

Leading players in the global pharmaceutical excipients for taste masking market, including Ashland Global Holdings Inc., BASF SE, and DOW Chemical Company, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced taste masking solutions, including novel flavor-masking agents and advanced coating materials, catering to diverse pharmaceutical needs and patient requirements. Collaborations with pharmaceutical manufacturers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving taste masking landscape.

Key Companies Profiled:

• Ashland Global Holdings Inc.
• BASF SE
• DOW Chemical Company
• Colorcon Inc.
• Ingredion Incorporated
• Roquette Freres
• JRS Pharma
• Lonza Group
• Evonik Industries AG
• Sensient Technologies Corporation

Key Segments Covered in Pharmaceutical Excipients for Taste Masking Industry Research

Excipient:

• Natural
• Artificial
• Nutritive
• Non- nutritive
• Polyols

Technique:

• Hot Melt Extrusion
• Microencapsulation
• Coating
• Organoleptic Methods

Usage:

• Solid Dosage Forms
• Liquid Dosage Forms

End-User:

• Pharmaceuticals
• Nutraceuticals
• Contract Manufacturing Organizations

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Excipient Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Recent Product Approval and Launches
• 4.4. Pipeline Assessment
• 4.5. PESTLE Analysis
• 4.6. Porter's Analysis
• 4.7. Regulatory Scenario

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Excipient Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising Geriatric Population
  • 5.2.2. Technological Advancements
  • 5.2.3. Adoption of Medicine for Paediatric Population
  • 5.2.4. Increasing Chronic Diseases
  • 5.2.5. Increasing Demand of Oral and Patients Compatible Medicines
  • 5.2.6. Growth of The Top Companies
  • 5.2.7. Mergers and Acquisitions
• 5.3. Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Excipient
  • 6.1.2. By Technique
  • 6.1.3. By Usage
  • 6.1.4. By End User
  • 6.1.5. By Region
• 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Excipient

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Excipient, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Excipient, 2024-2033
  • 8.3.1. Natural
  • 8.3.2. Artificial
  • 8.3.3. Nutritive
  • 8.3.4. Non- nutritive
  • 8.3.5. Polyols
  • 8.3.6. Others
• 8.4. Market Attractiveness Analysis By Excipient

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Technique

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Technique, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2024-2033
  • 9.3.1. Hot Melt Extrusion
  • 9.3.2. Microencapsulation
  • 9.3.3. Coating
  • 9.3.4. Organoleptic Methods
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis By Technique

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Usage

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By Usage, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2024-2033
  • 10.3.1. Solid Dosage Forms
    • 10.3.1.1. Tablets
    • 10.3.1.2. Granules
    • 10.3.1.3. Capsules
  • 10.3.2. Liquid Dosage Forms
• 10.4. Market Attractiveness Analysis By Usage

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
  • 11.3.1. Pharmaceuticals
  • 11.3.2. Nutraceuticals
  • 11.3.3. Contract Manufacturing Organizations
• 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. South Asia
  • 12.3.5. East Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Excipient
  • 13.3.3. By Technique
  • 13.3.4. By Usage
  • 13.3.5. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Excipient
  • 13.4.3. By Technique
  • 13.4.4. By Usage
  • 13.4.5. By End User
• 13.5. Country Level Analysis & Forecast
  • 13.5.1. U.S. Market Analysis
    • 13.5.1.1. Introduction
    • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.1.2.1. By Excipient
      • 13.5.1.2.2. By Technique
      • 13.5.1.2.3. By Usage
      • 13.5.1.2.4. By End User
  • 13.5.2. Canada Market Analysis
    • 13.5.2.1. Introduction
    • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.2.2.1. By Excipient
      • 13.5.2.2.2. By Technique
      • 13.5.2.2.3. By Usage
      • 13.5.2.2.4. By End User
• 13.6. Market Trends
• 13.7. Key Market Participants - Intensity Mapping
• 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Brazil
    • 14.3.1.2. Mexico
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Technique
  • 14.3.3. By Usage
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Excipient
  • 14.4.3. By Technique
  • 14.4.4. By Usage
  • 14.4.5. By End User
• 14.5. Country Level Analysis & Forecast
  • 14.5.1. Brazil Market Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Excipient
      • 14.5.1.2.2. By Technique
      • 14.5.1.2.3. By Usage
      • 14.5.1.2.4. By End User
  • 14.5.2. Mexico Market Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Excipient
      • 14.5.2.2.2. By Technique
      • 14.5.2.2.3. By Usage
      • 14.5.2.2.4. By End User
  • 14.5.3. Argentina Market Analysis
    • 14.5.3.1. Introduction
    • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.3.2.1. By Excipient
      • 14.5.3.2.2. By Technique
      • 14.5.3.2.3. By Usage
      • 14.5.3.2.4. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. France
    • 15.3.1.3. Italy
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. Russia
    • 15.3.1.7. BENELUX
    • 15.3.1.8. Nordic Countries
    • 15.3.1.9. Rest of Europe
  • 15.3.2. By Excipient
  • 15.3.3. By Technique
  • 15.3.4. By Usage
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Excipient
  • 15.4.3. By Technique
  • 15.4.4. By Usage
  • 15.4.5. By End User
• 15.5. Country Level Analysis & Forecast
  • 15.5.1. Germany Market Analysis
    • 15.5.1.1. Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Excipient
      • 15.5.1.2.2. By Technique
      • 15.5.1.2.3. By Usage
      • 15.5.1.2.4. By End User
  • 15.5.2. France Market Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Excipient
      • 15.5.2.2.2. By Technique
      • 15.5.2.2.3. By Usage
      • 15.5.2.2.4. By End User
  • 15.5.3. Italy Market Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Excipient
      • 15.5.3.2.2. By Technique
      • 15.5.3.2.3. By Usage
      • 15.5.3.2.4. By End User
  • 15.5.4. U.K. Market Analysis
    • 15.5.4.1. Introduction
    • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.4.2.1. By Excipient
      • 15.5.4.2.2. By Technique
      • 15.5.4.2.3. By Usage
      • 15.5.4.2.4. By End User
  • 15.5.5. Spain Market Analysis
    • 15.5.5.1. Introduction
    • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.5.2.1. By Excipient
      • 15.5.5.2.2. By Technique
      • 15.5.5.2.3. By Usage
      • 15.5.5.2.4. By End User
  • 15.5.6. Russia Market Analysis
    • 15.5.6.1. Introduction
    • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.6.2.1. By Excipient
      • 15.5.6.2.2. By Technique
      • 15.5.6.2.3. By Usage
      • 15.5.6.2.4. By End User
  • 15.5.7. Nordic Countries Market Analysis
    • 15.5.7.1. Introduction
    • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.7.2.1. By Excipient
      • 15.5.7.2.2. By Technique
      • 15.5.7.2.3. By Usage
      • 15.5.7.2.4. By End User
  • 15.5.8. BENELUX Market Analysis
    • 15.5.8.1. Introduction
    • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.8.2.1. By Excipient
      • 15.5.8.2.2. By Technique
      • 15.5.8.2.3. By Usage
      • 15.5.8.2.4. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Thailand
    • 16.3.1.3. Indonesia
    • 16.3.1.4. Malaysia
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Excipient
  • 16.3.3. By Technique
  • 16.3.4. By Usage
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Excipient
  • 16.4.3. By Technique
  • 16.4.4. By Usage
  • 16.4.5. By End User
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. India Market Analysis
    • 16.5.1.1. Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Excipient
      • 16.5.1.2.2. By Technique
      • 16.5.1.2.3. By Usage
      • 16.5.1.2.4. By End User
  • 16.5.2. Thailand Market Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Excipient
      • 16.5.2.2.2. By Technique
      • 16.5.2.2.3. By Usage
      • 16.5.2.2.4. By End User
  • 16.5.3. Indonesia Market Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Excipient
      • 16.5.3.2.2. By Technique
      • 16.5.3.2.3. By Usage
      • 16.5.3.2.4. By End User
  • 16.5.4. Malaysia Market Analysis
    • 16.5.4.1. Introduction
    • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.4.2.1. By Excipient
      • 16.5.4.2.2. By Technique
      • 16.5.4.2.3. By Usage
      • 16.5.4.2.4. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Excipient
  • 17.3.3. By Technique
  • 17.3.4. By Usage
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Excipient
  • 17.4.3. By Technique
  • 17.4.4. By Usage
  • 17.4.5. By End User
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. China Market Analysis
    • 17.5.1.1. Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Excipient
      • 17.5.1.2.2. By Technique
      • 17.5.1.2.3. By Usage
      • 17.5.1.2.4. By End User
  • 17.5.2. Japan Market Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Excipient
      • 17.5.2.2.2. By Technique
      • 17.5.2.2.3. By Usage
      • 17.5.2.2.4. By End User
  • 17.5.3. South Korea Market Analysis
    • 17.5.3.1. Introduction
    • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.3.2.1. By Excipient
      • 17.5.3.2.2. By Technique
      • 17.5.3.2.3. By Usage
      • 17.5.3.2.4. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Excipient
  • 18.3.3. By Technique
  • 18.3.4. By Usage
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Excipient
  • 18.4.3. By Technique
  • 18.4.4. By Usage
  • 18.4.5. By End User
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. Australia Market Analysis
    • 18.5.1.1. Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Excipient
      • 18.5.1.2.2. By Technique
      • 18.5.1.2.3. By Usage
      • 18.5.1.2.4. By End User
  • 18.5.2. New Zealand Market Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Excipient
      • 18.5.2.2.2. By Technique
      • 18.5.2.2.3. By Usage
      • 18.5.2.2.4. By End User
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkiye
    • 19.3.1.3. Northern Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Excipient
  • 19.3.3. By Technique
  • 19.3.4. By Usage
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Excipient
  • 19.4.3. By Technique
  • 19.4.4. By Usage
  • 19.4.5. By End User
• 19.5. Country Level Analysis & Forecast
  • 19.5.1. GCC Countries Market Analysis
    • 19.5.1.1. Introduction
    • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.1.2.1. By Excipient
      • 19.5.1.2.2. By Technique
      • 19.5.1.2.3. By Usage
      • 19.5.1.2.4. By End User
  • 19.5.2. Turkiye Market Analysis
    • 19.5.2.1. Introduction
    • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.2.2.1. By Excipient
      • 19.5.2.2.2. By Technique
      • 19.5.2.2.3. By Usage
      • 19.5.2.2.4. By End User
  • 19.5.3. Northern Africa Market Analysis
    • 19.5.3.1. Introduction
    • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.3.2.1. By Excipient
      • 19.5.3.2.2. By Technique
      • 19.5.3.2.3. By Usage
      • 19.5.3.2.4. By End User
  • 19.5.4. South Africa Market Analysis
    • 19.5.4.1. Introduction
    • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.4.2.1. By Excipient
      • 19.5.4.2.2. By Technique
      • 19.5.4.2.3. By Usage
      • 19.5.4.2.4. By End User
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Branding and Promotional Strategies
• 21.3. Key Development Analysis
• 21.4. Competition Deep Dive
  • 21.4.1. SPI Pharma, Inc.
    • 21.4.1.1. Overview
    • 21.4.1.2. Excipient Portfolio
    • 21.4.1.3. Key financials
    • 21.4.1.4. Sales Footprint
    • 21.4.1.5. Strategy Overview
      • 21.4.1.5.1. Marketing Strategy
      • 21.4.1.5.2. Product Strategy
      • 21.4.1.5.3. Channel Strategy
  • 21.4.2. Adare Pharmaceutical Inc.
    • 21.4.2.1. Overview
    • 21.4.2.2. Excipient Portfolio
    • 21.4.2.3. Key financials
    • 21.4.2.4. Sales Footprint
    • 21.4.2.5. Strategy Overview
      • 21.4.2.5.1. Marketing Strategy
      • 21.4.2.5.2. Product Strategy
      • 21.4.2.5.3. Channel Strategy
  • 21.4.3. GPT Pharmaceuticals Pvt. Ltd
    • 21.4.3.1. Overview
    • 21.4.3.2. Excipient Portfolio
    • 21.4.3.3. Key financials
    • 21.4.3.4. Sales Footprint
    • 21.4.3.5. Strategy Overview
      • 21.4.3.5.1. Marketing Strategy
      • 21.4.3.5.2. Product Strategy
      • 21.4.3.5.3. Channel Strategy
  • 21.4.4. Roquette Freres
    • 21.4.4.1. Overview
    • 21.4.4.2. Excipient Portfolio
    • 21.4.4.3. Key financials
    • 21.4.4.4. Sales Footprint
    • 21.4.4.5. Strategy Overview
      • 21.4.4.5.1. Marketing Strategy
      • 21.4.4.5.2. Product Strategy
      • 21.4.4.5.3. Channel Strategy
  • 21.4.5. Rochem International, Inc.
    • 21.4.5.1. Overview
    • 21.4.5.2. Excipient Portfolio
    • 21.4.5.3. Key financials
    • 21.4.5.4. Sales Footprint
    • 21.4.5.5. Strategy Overview
      • 21.4.5.5.1. Marketing Strategy
      • 21.4.5.5.2. Product Strategy
      • 21.4.5.5.3. Channel Strategy
  • 21.4.6. Gattefose
    • 21.4.6.1. Overview
    • 21.4.6.2. Excipient Portfolio
    • 21.4.6.3. Key financials
    • 21.4.6.4. Sales Footprint
    • 21.4.6.5. Strategy Overview
      • 21.4.6.5.1. Marketing Strategy
      • 21.4.6.5.2. Product Strategy
      • 21.4.6.5.3. Channel Strategy
  • 21.4.7. Asahi Kasei Corporation
    • 21.4.7.1. Overview
    • 21.4.7.2. Excipient Portfolio
    • 21.4.7.3. Key financials
    • 21.4.7.4. Sales Footprint
    • 21.4.7.5. Strategy Overview
      • 21.4.7.5.1. Marketing Strategy
      • 21.4.7.5.2. Product Strategy
      • 21.4.7.5.3. Channel Strategy
  • 21.4.8. DuPont de Nemours, Inc
    • 21.4.8.1. Overview
    • 21.4.8.2. Excipient Portfolio
    • 21.4.8.3. Key financials
    • 21.4.8.4. Sales Footprint
    • 21.4.8.5. Strategy Overview
      • 21.4.8.5.1. Marketing Strategy
      • 21.4.8.5.2. Product Strategy
      • 21.4.8.5.3. Channel Strategy
  • 21.4.9. Dow Pharma Solutions
    • 21.4.9.1. Overview
    • 21.4.9.2. Excipient Portfolio
    • 21.4.9.3. Key financials
    • 21.4.9.4. Sales Footprint
    • 21.4.9.5. Strategy Overview
      • 21.4.9.5.1. Marketing Strategy
      • 21.4.9.5.2. Product Strategy
      • 21.4.9.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology